SEC Form 5 · accession 0001209191-15-014845
CLEVELAND BIOLABS INC · CBLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julia R Brown
Director
Period of report
Dec 31, 2014
Accepted (ET)
Feb 17, 2015 · 7:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001318641
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.05 per shareF1,F2 | Oct 1, 2014 | A | 1,903 | $9.20 | A | 2,700 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person received a portion of her annual cash fees for services to be performed in 2014 as a member of the Board of Directors in shares of the Issuer's common stock.
- F2As adjusted for 20-to-1 reverse stock split, effective January 28, 2015.